S&P raises rating on Carilion Clinic’s bonds to ‘AA-‘

S&P Global Ratings raised the rating to “AA-” from “A+” on Roanoke, Va.-based Carilion Clinic’s revenue bonds.

Advertisement

“The upgrade to ‘AA-‘ reflects Carilion’s sustained improvement in its financial profile, with three consecutive years of operating margins over 3.5 percent[,] averaging 3.9 percent for fiscal years 2014 through 2016 … improved liquidity and financial flexibility that is consistent with ‘AA-‘ medians, and very strong enterprise profile with a solid and leading business position and experienced management team that is delivering on its key strategic initiatives, providing additional credit strength at the higher rating,” said S&P analyst Stephen Infranco.

The outlook is stable, reflecting S&P Global Ratings’ expectation the organization will sustain its recent operating improvement.

More articles on healthcare finance:
4 questions with Piedmont VP of revenue cycle Brian Unell
For-profit stock report: Week of May 22-26
California lawmakers want to use tobacco tax revenue for provider payments

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.